Physitrack preview Q4 2023: Strong cash generation expected - Redeye

Redeye anticipates that Physitrack’s Q4 2023 results will demonstrate robust cash generation, organic growth of 15% y/y, and sequentially sustained positive margin development. Physitrack is scheduled to publish its Q4 2023 report on 29 February at 08:00, followed by a conference call at 10:00. We reiterate our fair value range, with a base case of SEK38 per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/978071/physitrack-preview-q4-2023-strong-cash-generation-expected?utm_source=finwire&utm_medium=RSS